Skip to content
10-Q

Quarterly Report

AUTOLUS THERAPEUTICS PLC AUTL

0001730463-25-000067

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 266.14M sh
Shares Diluted Q2 2025 · Jun 30, 2025 266.14M sh
Shares Diluted Q2 2025 · Jun 30, 2025 266.13M sh
Shares Diluted Q2 2025 · Jun 30, 2024 266.03M sh
Shares Diluted Q2 2025 · Jun 30, 2024 255.13M sh
Capex Q2 2025 · Jun 30, 2025 $15.52M
Capex Q2 2025 · Jun 30, 2024 $1.37M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$148.35M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$91.6M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $123.83M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $227.38M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $705.94M
Stockholders Equity Q2 2025 · Jun 30, 2025 $346.46M
Stockholders Equity Q2 2025 · Mar 31, 2025 $371.11M
Stockholders Equity Q2 2025 · Dec 31, 2024 $427.33M
Stockholders Equity Q2 2025 · Jun 30, 2024 $527.84M
Stockholders Equity Q2 2025 · Mar 31, 2024 $582.03M
Stockholders Equity Q2 2025 · Dec 31, 2023 $111.47M
Current Liabilities Q2 2025 · Jun 30, 2025 $68.15M
Current Liabilities Q2 2025 · Dec 31, 2024 $60.74M
Total Liabilities Q2 2025 · Jun 30, 2025 $374.52M
Total Liabilities Q2 2025 · Dec 31, 2024 $355.4M
Current Assets Q2 2025 · Jun 30, 2025 $574.25M
Current Assets Q2 2025 · Dec 31, 2024 $660.93M
Total Assets Q2 2025 · Jun 30, 2025 $720.98M
Total Assets Q2 2025 · Dec 31, 2024 $782.73M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.18
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.44
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.22
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.43
Eps Basic Q2 2025 · Jun 30, 2025 −$0.18
Eps Basic Q2 2025 · Jun 30, 2025 −$0.44
Eps Basic Q2 2025 · Jun 30, 2024 −$0.22
Eps Basic Q2 2025 · Jun 30, 2024 −$0.43
Sga Expense Q2 2025 · Jun 30, 2025 $30.27M
Sga Expense Q2 2025 · Jun 30, 2025 $59.8M
Sga Expense Q2 2025 · Jun 30, 2024 $21.9M
Sga Expense Q2 2025 · Jun 30, 2024 $40.08M
Rd Expense Q2 2025 · Jun 30, 2025 $27.43M
Rd Expense Q2 2025 · Jun 30, 2025 $54.16M
Rd Expense Q2 2025 · Jun 30, 2024 $36.61M
Rd Expense Q2 2025 · Jun 30, 2024 $67.28M
Net Income Q2 2025 · Jun 30, 2025 −$47.92M
Net Income Q2 2025 · Jun 30, 2025 −$118.08M
Net Income Q2 2025 · Mar 31, 2025 −$70.16M
Net Income Q2 2025 · Jun 30, 2024 −$58.27M
Net Income Q2 2025 · Jun 30, 2024 −$110.96M
Net Income Q2 2025 · Mar 31, 2024 −$52.69M
Operating Income Q2 2025 · Jun 30, 2025 −$61.22M
Operating Income Q2 2025 · Jun 30, 2025 −$126.46M
Operating Income Q2 2025 · Jun 30, 2024 −$58.93M
Operating Income Q2 2025 · Jun 30, 2024 −$97.69M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $24.45M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $42.4M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $0
Cost Of Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2025 $20.92M
Revenue Q2 2025 · Jun 30, 2025 $29.91M
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $10.09M